Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 10/20 | 0.51 |
| ▸ | EHMT1 | Q9H9B1 | 10/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HAVCR2 | Q8TDQ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30330220 | 1.00 | EHMT2 (0.51) | EHMT2EHMT1KCNH2NPC1RAB9A | |
| SCHEMBL30329919 | 0.93 | EHMT2 (0.51) | EHMT2EHMT1SMN1; SMN2 | |
| SCHEMBL25166190 | 0.93 | EHMT2 (0.51) | EHMT2EHMT1SMN1; SMN2 | |
| SCHEMBL30330204 | 0.87 | EHMT2 (0.68) | EHMT2EHMT1KCNH2HAVCR2 | |
| SCHEMBL25166432 | 0.87 | EHMT2 (0.68) | EHMT2EHMT1KCNH2HAVCR2 | |
| SCHEMBL25165900 | 0.85 | EHMT2 (0.51) | EHMT2EHMT1 | |
| SCHEMBL25166244 | 0.82 | EHMT2 (0.49) | EHMT2EHMT1NPC1RAB9AKMT2A | |
| SCHEMBL30329788 | 0.82 | EHMT2 (0.49) | EHMT2EHMT1NPC1RAB9AKMT2A | |
| SCHEMBL31168666 | 0.80 | EHMT2 (0.49) | EHMT2EHMT1 | |
| SCHEMBL25166159 | 0.79 | EHMT2 (0.68) | EHMT2EHMT1HAVCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023064586-A1 | NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF | TANGO THERAPEUTICS, INC. (US) | 2023-04-20 | — | — | WO | disclosed |